Form4insider filings, from the source

SEC Form 4 · accession 0001077183-19-000031

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
George Cardoza
Officer — President, Pharma Services
Period of report
Mar 1, 2019
Accepted (ET)
Mar 5, 2019 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockMar 1, 2019A8,418$0.00A252,507D
Common Stockholding———20,000ITrust by Self

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F1$19.60Mar 1, 2019A51,459AMar 1, 2020Mar 1, 2024Common Stock51,45951,459D
Stock Option (Right to Buy)F2$4.78holding———May 4, 2016May 4, 2020Common Stock200,000200,000D
Stock Option (Right to Buy)F3$7.15holding———Apr 20, 2017Apr 20, 2021Common Stock200,000200,000D
Stock Option (Right to Buy)F4$7.52holding———Apr 28, 2018Apr 28, 2022Common Stock200,000200,000D
Stock Options (Right to Buy)F5$8.03holding———Feb 26, 2019Feb 26, 2023Common Stock192,500192,500D

Explanation of responses